A study to find out if 3 injections with a vaccine (given over the course of 30 days) to prevent infection with Clostridium difficile (C difficile) is safe and well tolerated in healthy people who were 50 to 85 years of age

A Phase 2, placebo-controlled, randomized, observer-blinded trial to evaluate the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered as a 3-dose regimen in healthy adults aged 50 to 85 years

Category & Conditions: Vaccine-related Conditions

Medicine: PF-06425090

ClinicalTrials.gov Identifier (NCT): NCT02117570

Protocol ID: B5091003

Print Download

Open Plain Language Summary Result: Click here